Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (24862)
All Articles published online
|
Publishing Process of This Article
|
Oct 21, 2015 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marino L, Jornayvaz FR. Endocrine causes of nonalcoholic fatty liver disease. World J Gastroenterol 2015; 21(39): 11053-11076 [PMID: 26494962 DOI: 10.3748/wjg.v21.i39.11053] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i39/11053.htm |
| Number | Citing Articles |
| 1 |
Patrice Marques, Vera Francisco, Laura Martínez-Arenas, Ângela Carvalho-Gomes, Elena Domingo, Laura Piqueras, Marina Berenguer, Maria-Jesus Sanz. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(3): 2313 doi: 10.3390/ijms24032313
|
| 2 |
L. J. Yang, J. Z. Zhou, Y. F. Zheng, X. Hu, Z. Y. He, L. J. Du, X. Gu, X. Y. Huang, J. Li, Y. Q. Li, L. Y. Pan, X. X. Zhang, X. J. Gu. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus. Journal of Endocrinological Investigation 2023; 46(8): 1565 doi: 10.1007/s40618-023-02006-6
|
| 3 |
Matina Kouvari, Laura Valenzuela‐Vallejo, Evangelos Axarloglou, Ornella Verrastro, Georgios Papatheodoridis, Geltrude Mingrone, Jacob George, Christos S. Mantzoros. Thyroid function, adipokines and mitokines in metabolic dysfunction‐associated steatohepatitis: A multi‐centre biopsy‐based observational study. Liver International 2024; 44(3): 848 doi: 10.1111/liv.15847
|
| 4 |
Qingwen Qian, Mark Li, Zeyuan Zhang, Shannon W. Davis, Kamal Rahmouni, Andrew W. Norris, Huojun Cao, Wen-Xing Ding, Gökhan S. Hotamisligil, Ling Yang. Obesity disrupts the pituitary-hepatic UPR communication leading to NAFLD progression. Cell Metabolism 2024; 36(7): 1550 doi: 10.1016/j.cmet.2024.04.014
|
| 5 |
Naser Khalaji, Ahad Zeinali, Masomeh Purjabali, Kia Bolurani, Amin Abdollahazade Fard. The Effect of Bioactive Component of Turmeric (curcumin) on Liver Complications - Induced by Compact Fluorescent Lamps (CFLs) in Rats. Shiraz E-Medical Journal 2018; (In Press) doi: 10.5812/semj.60572
|
| 6 |
Anaïs Vallet-Pichard, Lucia Parlati, Stanislas Pol. Épidémiologie de la stéato-hépatite non alcoolique. Étendue du problème et son impact sur la santé publique. La Presse Médicale 2019; 48(12): 1459 doi: 10.1016/j.lpm.2019.08.008
|
| 7 |
Ye Shiren, Ye Jiangnan, Ye Xinhua, Ni Xinye. Interpretable prediction model for assessing diabetes complication risks in Chinese sufferers. Diabetes Research and Clinical Practice 2024; 209: 111560 doi: 10.1016/j.diabres.2024.111560
|
| 8 |
Clarissa Berardo, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Mariapia Vairetti, Andrea Ferrigno. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. International Journal of Molecular Sciences 2020; 21(24): 9646 doi: 10.3390/ijms21249646
|
| 9 |
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
|
| 10 |
Soo-Hyun Lee, Moon-Jong Kim, Young-Sang Kim, Hyejin Chun, Bo Youn Won, Joo-Ho Lee, Kunhee Han, Kyu-Sung Rim, Kyung-Chae Park. Low hair copper concentration is related to a high risk of nonalcoholic fatty liver disease in adults. Journal of Trace Elements in Medicine and Biology 2018; 50: 28 doi: 10.1016/j.jtemb.2018.06.001
|
| 11 |
Yusuf Karadeniz. Current Perspective on Diabetes Mellitus in Clinical Sciences. 2023; : 63 doi: 10.69860/nobel.9786053359111.7
|
| 12 |
Shuangshuang Xie, Qing Li, Yue Cheng, Yu Zhang, Zhizheng Zhuo, Guiming Zhao, Wen Shen. Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study. Korean Journal of Radiology 2017; 18(6): 898 doi: 10.3348/kjr.2017.18.6.898
|
| 13 |
Adriana Claudia Lopes Carvalho-Furtado, Daniela Mariano Carvalho-Louro, Neysa Aparecida Tinoco Regattieri, Marcelo Palmeira Rodrigues, Maria Luiza Ricardo Nogueira Montenegro, André Metzker Ferro, Patrícia Souza Pirangi, Luciana Ansaneli Naves. Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00364
|
| 14 |
Bo-Youn Won, Kyung-Chae Park, Soo-Hyun Lee, Sung-Hwan Yun, Moon-Jong Kim, Kye-Seon Park, Young-Sang Kim, Ji-Hee Haam, Hyung-Yuk Kim, Hye-Jung Kim, Ki-Hyun Park. Sex Difference in the Association between Serum Homocysteine Level and Non-Alcoholic Fatty Liver Disease. Korean Journal of Family Medicine 2016; 37(4): 242 doi: 10.4082/kjfm.2016.37.4.242
|
| 15 |
Aynur ARSLAN, Emine KARTAL BAYKAN, Nazligul KARAUZUM YALCIN, Mustafa UTLU, Havva Tugba KIPER YILMAZ, Alperen Akansel CAGLAR, Emre DEVE, Emrah DOGAN, Ayse CARLIOGLU. Fatty liver in patients with acromegaly. Turkish Journal of Clinics and Laboratory 2020; 11(1): 33 doi: 10.18663/tjcl.604304
|
| 16 |
Castillo Tomas Augusto, María de la Paz Scribano Parada, Micaela Milagros Rossi, Franco Signorini, Ismael Fonseca, María del Carmen Baez. Pharmacological Action of Atorvastatin and Metformin on Non-alcoholic
Fatty Liver Disease on an Experimental Model of Metabolic Syndrome. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2021; 21(3): 194 doi: 10.2174/1871523022666230223090714
|
| 17 |
Benjamin T. House, Grace E. Shearrer, Jessica B. Boisseau, Molly S. Bray, Jaimie N. Davis. Decreased eating frequency linked to increased visceral adipose tissue, body fat, and BMI in Hispanic college freshmen. BMC Nutrition 2018; 4(1) doi: 10.1186/s40795-018-0217-z
|
| 18 |
Ya-Di Wang, Liang-Liang Wu, Xiao-Yan Qi, Yuan-Yuan Wang, Zhe-Zhen Liao, Jiang-Hua Liu, Xin-Hua Xiao. New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?. Genes & Diseases 2023; 10(3): 799 doi: 10.1016/j.gendis.2021.12.013
|
| 19 |
So Yoon Jung, Yun Jeong Lee, Hye Jin Lee, Young Ah Lee, Jin Soo Moon, Jae Sung Ko, Sei Won Yang, Choong Ho Shin. Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma. Annals of Pediatric Endocrinology & Metabolism 2017; 22(3): 189 doi: 10.6065/apem.2017.22.3.189
|
| 20 |
Abhishek Kulkarni, Sara Ibrahim, Isra Haider, Amina Basha, Emma Montgomery, Ebru Ermis, Raghavendra G. Mirmira, Ryan M. Anderson. A Novel 2-Hit Zebrafish Model to Study Early Pathogenesis of Non-Alcoholic Fatty Liver Disease. Biomedicines 2022; 10(2): 479 doi: 10.3390/biomedicines10020479
|
| 21 |
Manjunath Ramanjaneya, Ilham Bettahi, Jayakumar Jerobin, Prem Chandra, Charbel Abi Khalil, Monica Skarulis, Stephen Lawrence Atkin, Abdul-Badi Abou-Samra. Mitochondrial-Derived Peptides Are Down Regulated in Diabetes Subjects. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00331
|
| 22 |
Llorenç Caballería Rovira, Irfan Majeed, Alba Martínez Escudé, Ingrid Arteaga Pillasagua, Pere Torán Monserrat. Esteatosis hepática: diagnóstico y seguimiento. FMC - Formación Médica Continuada en Atención Primaria 2017; 24(7): 378 doi: 10.1016/j.fmc.2017.03.001
|
| 23 |
Mojtaba Rahmani, Masoumeh Nezhadali, Javad Rastegar Moghaddam. Association of adiponectin level with biochemical variables and insulin resistance in patients with non-alcoholic fatty liver disease in an Iranian population. MEDICAL SCIENCES JOURNAL 2019; 29(4): 329 doi: 10.29252/iau.29.4.329
|
| 24 |
Eleonore Fröhlich, Richard Wahl. Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease. Metabolites 2022; 12(8): 718 doi: 10.3390/metabo12080718
|
| 25 |
Kate A Harrington, David S Kennedy, Bobby Tang, Conor Hickie, Emma Phelan, William Torreggiani, Darragh Halpenny. Computed tomographic evaluation of the thymus—does obesity affect thymic fatty involution in a healthy young adult population?. The British Journal of Radiology 2018; : 20170609 doi: 10.1259/bjr.20170609
|
| 26 |
Yueying Qi, Lirong Fan, Decong Ran, Jieda Xu, Yuansong Wang, Jin Wu, Zhongyong Zhang, Muhammad Wasim Khan. Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/7764817
|
| 27 |
Xiao-Yuan Zhang, Ke Yuan, Yan-Lan Fang, Chun-Lin Wang. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World Journal of Clinical Cases 2022; 10(18): 6211-6217 doi: 10.12998/wjcc.v10.i18.6211
Abstract(554) |
Core Tip(479) |
Full Article(HTML)(2120)
|
Full Article (PDF)-4863K(242)
|
Full Article (Word)-1467K(71)
|
Audio-528K(2)
|
Peer-Review Report-231K(67)
|
Answering Reviewers-135K(64)
|
Times Cited (0)
|
Total Visits (6135)
|
Open
|
| 28 |
Hakan Fotbolcu, Elçin Zorlu. Nonalcoholic fatty liver disease as a multi-systemic disease. World Journal of Gastroenterology 2016; 22(16): 4079-4090 doi: 10.3748/wjg.v22.i16.4079
|
| 29 |
Hessah Al‑Muzafar, Kamal Amin. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6563
|
| 30 |
Maria Mavromati, François R. Jornayvaz. Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD. International Journal of Molecular Sciences 2021; 22(23): 12797 doi: 10.3390/ijms222312797
|
| 31 |
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólico. Revista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
|
| 32 |
Peng Cui, Wei Hu, Tong Ma, Min Hu, Xiaoyu Tong, Feifei Zhang, Jiemei Shi, Xiaoqing Xu, Xin Li, Linus Ruijin Shao, Håkan Billig, Yi Feng. Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats. The Journal of Steroid Biochemistry and Molecular Biology 2021; 208: 105829 doi: 10.1016/j.jsbmb.2021.105829
|
| 33 |
Michael R. Minicozzi, Erik G. Axlid, Frank A. von Hippel, Joseph Espinoza, Aubrey Funke, Quentin P. Phillips, C. Loren Buck, Michael W. Greene. Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish. PLOS ONE 2021; 16(8): e0254500 doi: 10.1371/journal.pone.0254500
|
| 34 |
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
|
| 35 |
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032361
|
| 36 |
Madalena Von-Hafe, Marta Borges-Canha, Catarina Vale, Ana Rita Leite, João Sérgio Neves, Davide Carvalho, Adelino Leite-Moreira. Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review. Metabolites 2022; 12(4): 298 doi: 10.3390/metabo12040298
|
| 37 |
Marcin Banaszczak, Dominika Maciejewska, Arleta Drozd, Karina Ryterska, Dominika Jamioł Milc, Joanna Raszeja-Wyszomirska, Ewa Wunsch, Pedro González-Muniesa, Ewa Stachowska. 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease. Medicina 2020; 56(2): 58 doi: 10.3390/medicina56020058
|
| 38 |
Hong Phan, Aline Richard, Mariana Lazo, William G. Nelson, Samuel R. Denmeade, John Groopman, Norma Kanarek, Elizabeth A. Platz, Sabine Rohrmann. The association of sex steroid hormone concentrations with non‐alcoholic fatty liver disease and liver enzymes in US men. Liver International 2021; 41(2): 300 doi: 10.1111/liv.14652
|
| 39 |
Myeong Jun Song, Jong Young Choi. Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1053709
|
| 40 |
Harpreet Grewal, Sandeep Joshi, Ruby Sharma, Puneet Mittal, Ankur Goel. Non-alcoholic fatty liver disease in patients with hypothyroidism presenting at a rural tertiary care centre in north India. Tropical Doctor 2021; 51(2): 181 doi: 10.1177/0049475520945058
|
| 41 |
Melanie Schranz, Maria Grazia Lucà, Lorenzo D’Antiga, Stefano Fagiuoli. Pediatric Hepatology and Liver Transplantation. 2019; : 361 doi: 10.1007/978-3-319-96400-3_22
|
| 42 |
Ruben Vazquez-Uribe, Karl Alex Hedin, Tine Rask Licht, Max Nieuwdorp, Morten O.A. Sommer. Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases. Trends in Endocrinology & Metabolism 2024; doi: 10.1016/j.tem.2024.04.021
|
| 43 |
Luigi Marino, Adam Kim, Bin Ni, Francesco S. Celi. Thyroid hormone action and liver disease, a complex interplay. Hepatology 2023; doi: 10.1097/HEP.0000000000000551
|
| 44 |
İmdat Eroğlu, Burcin Gonul Iremli, Ilkay S Idilman, Deniz Yuce, Incilay Lay, Deniz Akata, Tomris Erbas. Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Utility of Noninvasive Scores in Patients With Acromegaly. The Journal of Clinical Endocrinology & Metabolism 2023; 109(1): e119 doi: 10.1210/clinem/dgad490
|
| 45 |
Florianne O L Vehmeijer, Susana Santos, Romy Gaillard, Yolanda B de Rijke, Trudy Voortman, Erica L T van den Akker, Janine F Felix, Elisabeth F C van Rossum, Vincent W V Jaddoe. Associations of Hair Cortisol Concentrations with General and Organ Fat Measures in Childhood. The Journal of Clinical Endocrinology & Metabolism 2021; 106(2): e551 doi: 10.1210/clinem/dgaa785
|
| 46 |
Hong Yao, Yan Hu, Haibing Tong, Shourong Shi. Dimethylglycine Alleviates Metabolic Dysfunction-Associated Fatty Liver Disease by Improving the Circulating Estrogen Level via Gut Staphylococcus. Journal of Agricultural and Food Chemistry 2024; 72(5): 2708 doi: 10.1021/acs.jafc.3c07075
|
| 47 |
Seongha Cho, Adnan Khan, Sun Ha Jee, Hee-Seok Lee, Myung-Sil Hwang, Yong Eui Koo, Youngja H. Park. High resolution metabolomics to determines the risk associated with bisphenol A exposure in humans. Environmental Toxicology and Pharmacology 2018; 58: 1 doi: 10.1016/j.etap.2017.12.008
|
| 48 |
Yi Chen, Xueyang Chen, Qiang Chen, Chaohui Yu. Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.565714
|
| 49 |
Hongying Yang, Dongyun Wei, Yao Zhang, Wenxuan Jian. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty
Liver Disease in High Fat-diet Mice. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(6): 691 doi: 10.2174/0118715303257018230927182802
|
| 50 |
Peizhu Chen, Xuhong Hou, Li Wei, Liang Feng, Lichang Zhong, Lei Jiao, Hongmei Wang, Yuqian Bao, Weiping Jia. Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. European Journal of Clinical Investigation 2019; 49(4) doi: 10.1111/eci.13070
|
| 51 |
Brigitte Leeners, Nori Geary, Philippe N. Tobler, Lori Asarian. Ovarian hormones and obesity. Human Reproduction Update 2017; 23(3): 300 doi: 10.1093/humupd/dmw045
|
| 52 |
Kazuki Tahara, Takemi Akahane, Tadashi Namisaki, Kei Moriya, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Shinya Sato, Soichiro Saikawa, Keisuke Nakanishi, Takuya Kubo, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Yuuki Tsuji, Daisuke Kaya, Hiroyuki Ogawa, Hirotetsu Takagi, Koji Ishida, Akira Mitoro, Hitoshi Yoshiji. Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease. JGH Open 2020; 4(3): 400 doi: 10.1002/jgh3.12264
|
| 53 |
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
|
| 54 |
Jill Roberts Hobbs, Kimberly Ellison Wilson. Obesity in Primary Care: A Case of Endocrine-Associated Conditions. The Journal for Nurse Practitioners 2023; 19(3): 104489 doi: 10.1016/j.nurpra.2022.10.018
|
| 55 |
Caroline E Geisler, Benjamin J Renquist. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. Journal of Endocrinology 2017; 234(1): R1 doi: 10.1530/JOE-16-0513
|
| 56 |
Anna Jeznach-Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka-Senczyna, Iwona Boniecka, Urszula Shahnazaryan, Alina Kuryłowicz. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. Medicina 2019; 55(5): 166 doi: 10.3390/medicina55050166
|
| 57 |
Xinhe Zhang, Haoyu Tian, Yiling Li. The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease. iLIVER 2022; 1(1): 65 doi: 10.1016/j.iliver.2022.02.004
|
| 58 |
Askhi M. Valodara, Kaid Johar SR. Sexual Dimorphism in Drug Metabolism and Pharmacokinetics. Current Drug Metabolism 2020; 20(14): 1154 doi: 10.2174/1389200220666191021094906
|
| 59 |
XuanJi Li, Christopher Rensing, William L. Taylor, Caitlin Costelle, Asker Daniel Brejnrod, Robert J. Ferry, Paul B. Higgins, Franco Folli, Kameswara Rao Kottapalli, Gene B. Hubbard, Edward J. Dick, Shibu Yooseph, Karen E. Nelson, Natalia Schlabritz‐Loutsevitch. Papiospp. Colon microbiome and its link to obesity in pregnancy. Journal of Medical Primatology 2018; 47(6): 393 doi: 10.1111/jmp.12366
|
| 60 |
Sabine Hörist-Kollmann, Jeanette Strametz-Juranek. Female Dietary Patterns and the Pathogenesis of NAFLD. Gender and the Genome 2018; 2(2): 49 doi: 10.1177/2470289718787091
|